AKTX
Akari Therapeutics, Plc
NASDAQ · Healthcare · Biotechnology · GB
$11.77
+8.58%Next report
Analyst consensus
- Next report date
- Dec 4, 2026
- EPS estimate
- -$2.09
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$272
- EPS estimate
- -$1.04
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12192222.5%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 4, 2026